Low serum albumin, clinically called hypoalbuminemia, signals that something has gone wrong with the body’s production, retention, or distribution of its most abundant blood protein. A healthy level generally falls between 3.5 and 5.0 g/dL, and readings below about 3.5 g/dL prompt clinical concern. The causes range from liver disease and kidney problems to severe inflammation and poor nutrition, and the condition itself is one of the strongest predictors of poor outcomes in hospitalized patients. Understanding why albumin drops, what it feels like, and what can be done about it matters because the number on the lab report is rarely the whole story.
What Albumin Actually Does
Albumin is the single most plentiful protein in blood plasma. It performs two jobs that are hard to replace. First, it acts as a carrier molecule, shuttling fatty acids, hormones, calcium, and many drugs through the bloodstream. Second, it maintains what clinicians call oncotic pressure, the force that keeps fluid inside blood vessels instead of leaking into surrounding tissues. When albumin drops low enough, fluid escapes into spaces where it does not belong, which is why swelling is one of the hallmark signs. Albumin also binds toxins and free radicals, contributing to the body’s detoxification capacity.
Common Causes of Low Albumin
A low reading on a blood test almost always reflects one or more of four broad problems: the liver is making less albumin, the kidneys or gut are losing it, the body is redistributing it because of inflammation, or nutritional intake is too low to keep up with demand. In practice, these categories overlap. A person with cirrhosis, for example, often has both reduced production and increased inflammation. A person in an intensive care unit may have all four mechanisms working at once.
Liver Disease
The liver is the sole manufacturing site for albumin. In advanced cirrhosis, the sheer loss of functional liver cells reduces how much albumin the organ can make. Repeated therapeutic procedures such as large-volume paracentesis (draining fluid from the abdomen) compound the problem by physically removing albumin-rich fluid faster than the liver can replace it.1PubMed. Albumin in Advanced Liver Diseases: The Good and Bad of a Drug! In early-stage liver disease, albumin levels can stay normal for a surprisingly long time because the liver has a large functional reserve. It is often only after significant damage accumulates that levels begin to fall.
Kidney Loss
Healthy kidneys keep albumin in the blood. In nephrotic syndrome and other conditions that damage the kidney’s filtering membranes, albumin spills into the urine in large quantities. This urinary loss can outpace the liver’s ability to ramp up production, and the resulting drop in albumin contributes to severe swelling in the legs, face, and abdomen. When albumin falls below roughly 2.0 to 2.5 g/dL from renal losses, visible edema becomes almost universal.
Gastrointestinal Loss
Protein-losing enteropathy is a less familiar cause but an important one in conditions such as Crohn’s disease, celiac disease, and intestinal lymphangiectasia. In these situations, protein leaks through inflamed or damaged gut lining into the intestinal tract, and the liver cannot produce replacement protein fast enough to keep up.2PubMed Central. Protein-Losing Enteropathy in Crohn’s Disease: Two Unusual Cases Because albumin loss through the gut is harder to measure than urinary loss, this cause can go unrecognized for months.
Inflammation and Critical Illness
This is probably the most underappreciated driver. During any significant inflammatory state, whether from sepsis, major surgery, burns, or a flare of an autoimmune disease, blood vessels become leakier. Inflammatory molecules trigger capillaries to widen their pores, letting albumin escape from the bloodstream into surrounding tissues at greatly increased rates.3PubMed Central. Hypoalbuminemia: Pathogenesis and Clinical Significance At the same time, the liver shifts its priorities from making albumin to producing acute-phase proteins like C-reactive protein and fibrinogen that help fight infection. The result is a rapid, sometimes dramatic drop in measured serum albumin that has little to do with nutrition or liver function. In critically ill patients, albumin can fall within hours of the onset of a severe infection.
Signs and Symptoms
Mild hypoalbuminemia often produces no obvious symptoms. Many people first learn about it from a routine blood test. As levels fall further, symptoms typically build in a predictable pattern:
- Edema: Swelling in the ankles, feet, hands, or around the eyes. This becomes clinically apparent when albumin drops below roughly 2.5 g/dL, because there is no longer enough oncotic pressure to keep fluid in the blood vessels.
- Ascites: Accumulation of fluid in the abdominal cavity, particularly common in liver disease. The abdomen feels distended and tight.
- Fatigue and weakness: These are nonspecific but almost universal once albumin is significantly low, partly because the underlying cause (liver disease, infection, malnutrition) produces its own symptoms.
- Poor wound healing: Albumin carries nutrients and growth factors to tissues, so low levels slow the repair process.
- Muscle wasting: In chronic hypoalbuminemia, the body breaks down muscle to free amino acids for protein synthesis elsewhere.
Edema from low albumin is characteristically “pitting,” meaning a thumb pressed into the swollen area leaves an indent that slowly fills back in. It tends to be symmetric and worse in dependent areas (feet when standing, the lower back when lying down).
The Malnutrition Misconception
For decades, a low albumin level was treated as a marker of poor nutrition. Hospital dietary consults would be triggered automatically by a low result, and nutrition support teams would focus on raising the number through feeding. The reality is more complicated, and the field has shifted its understanding considerably.
Low albumin in chronic disease turns out to reflect inflammation more than food intake. Both inflammation and inadequate nutrition reduce how fast the liver makes albumin, but inflammation adds an extra blow by speeding up albumin breakdown and pushing it out of the bloodstream into tissues.4PubMed. Serum albumin: relationship to inflammation and nutrition This means that aggressively feeding a septic patient or someone recovering from major surgery will not reliably raise their albumin level, because the inflammatory process is the dominant force pulling it down.
International nutrition guidelines have caught up with this evidence. The Global Leadership Initiative on Malnutrition (GLIM) consensus and European nutrition guidelines now treat albumin as an indicator of disease severity and inflammation rather than a direct measure of nutritional status. A recent expert consensus specifically concluded that serum albumin lacks validity for diagnosing malnutrition when inflammatory conditions are present.5Clinical Nutrition. The clinical significance of hypoalbuminaemia
That said, nutrition is not irrelevant. In settings where inflammation is minimal, such as long-stay geriatric units, protein intake does correlate with albumin levels, and suboptimal diets can contribute to low readings.6PubMed. Protein intake and serum albumin levels in the elderly The practical takeaway: when albumin is low, check for inflammation first. If inflammatory markers are normal, then inadequate nutrition becomes a more plausible explanation.
Why Surgeons Pay Close Attention
Few lab values predict surgical outcomes as reliably as serum albumin. A large analysis from the National VA Surgical Risk Study found that as albumin dropped from above 4.6 g/dL to below 2.1 g/dL, the 30-day mortality rate rose exponentially, from under 1% to 29%, and complication rates climbed from 10% to 65%. Albumin was a stronger predictor of death and serious infection than many other preoperative measures.7PubMed. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study
More recent data from the National Surgical Quality Improvement Program confirms the pattern: after adjusting for other risk factors, patients with hypoalbuminemia had roughly double the odds of dying within 30 days of surgery compared to those with normal levels.8PubMed Central. The Association between Serum Albumin and Post-Operative Outcomes among Patients Undergoing Common Surgical Procedures When albumin is severely low (below about 2.5 g/dL), the risk of in-hospital death can be several times higher still.9PubMed Central. The Association of Pre-operative Serum Albumin Levels and Post-operative In-Hospital Death in Patients Undergoing Gastrointestinal Surgeries in Thailand
Albumin is not causing these poor outcomes on its own. Rather, a low level flags the combined burden of malnutrition, chronic disease, and inflammation that makes a patient vulnerable. For surgeons, though, it serves as a practical red flag: a patient with a very low albumin going into an operation needs careful optimization beforehand, or the team may consider whether a less invasive approach is safer.
Treatment Approaches
There is no single treatment for low albumin because it is a consequence of underlying problems, not a standalone disease. The most effective intervention is almost always treating whatever caused the drop in the first place. Antibiotics for an infection, immunosuppressive therapy for an inflammatory condition, or managing cirrhosis more effectively will do far more for albumin levels than trying to push the number up directly.
Intravenous Albumin
Albumin can be given as an intravenous infusion, and it is widely used in hospitals. But the evidence for when this actually helps is narrower than many clinicians assume. International transfusion guidelines recommend IV albumin in a handful of specific scenarios related to cirrhosis: after large-volume paracentesis (draining more than 5 liters of ascites fluid), to reduce mortality in spontaneous bacterial peritonitis, and potentially during hepatorenal syndrome. Outside these situations, routine albumin infusion for patients with low levels has not clearly improved outcomes.10PubMed Central. Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines
The same guidelines specifically recommend against routinely giving IV albumin to hospitalized cirrhosis patients just to push their albumin above 3.0 g/dL, or to outpatients with uncomplicated ascites. Albumin infusions are expensive, and hospitals have increasingly implemented stewardship programs to ensure the product is reserved for situations where evidence supports its use.11PubMed Central. Evaluation of Albumin 25% Use in Critically Ill Patients at a Tertiary Care Medical Center
Dietary Protein
In patients whose albumin is low partly due to inadequate nutrition, increasing protein intake can help. Research in older adults at risk of sarcopenia found that the link between low albumin and mortality was significantly stronger in people with low dietary protein intake. Among those with higher protein intake, the association between low albumin and death was weaker and not statistically significant after adjustment, suggesting that adequate protein may buffer some of the risk.12Heliyon. Associations of serum albumin and dietary protein intake with all-cause mortality in community-dwelling older adults at risk of sarcopenia This does not mean eating more protein will raise a critically ill patient’s albumin level in the short term, but it supports the idea that long-term nutritional adequacy matters for maintaining albumin over time.
Addressing Fluid Overload
In postoperative and critically ill patients, some of what looks like low albumin on a lab test is actually a dilution effect. Large volumes of IV fluid expand the blood volume and dilute albumin concentrations without the total amount of albumin in the body changing much. One study of postoperative patients found that those whose albumin fell below 2.7 g/dL after surgery developed significantly more fluid overload than those above that threshold.13Annals of the Royal College of Surgeons of England. Low plasma albumin linked to fluid overload in postoperative epidural patients Careful fluid management, including diuretics when appropriate, can help normalize the measured value without directly replacing albumin.
How Low Albumin Changes the Way Drugs Work
Albumin binds many commonly used medications and carries them through the bloodstream. When albumin is low, a larger fraction of certain drugs circulates unbound, or “free,” in the blood. Since it is the free drug that is pharmacologically active, this can theoretically increase a drug’s effect and its toxicity at the same dose. Monitoring drug levels becomes especially important in hospitalized patients with hypoalbuminemia.14PubMed Central. Effect of hypoalbuminemia on drug pharmacokinetics
However, the clinical picture is not as straightforward as it sounds, and there is a persistent misunderstanding in the medical literature. For most drugs, the body compensates: when more free drug is available, the liver and kidneys clear it faster, so the steady-state concentration of active drug does not actually change much. The exceptions are a small number of highly protein-bound anesthetics with high elimination capacity, and even these represent fewer than five drugs on the market.15PubMed Central. Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades For the vast majority of medications, low albumin does not meaningfully change how much active drug reaches its target. Clinicians who reflexively adjust doses downward for every patient with low albumin may inadvertently underdose them.
Lab Testing Is Not as Simple as It Looks
Most hospitals measure albumin using one of two dye-binding assays: bromocresol green (BCG) or bromocresol purple (BCP). These are fast and cheap, but they do not always agree, and the difference can be clinically meaningful. The BCG assay reacts not only with albumin but also with other proteins, particularly alpha-2-macroglobulin, which rises in inflammatory and nephrotic states. This means BCG can overestimate albumin in exactly the patients where accuracy matters most.16PubMed. The bromocresol green assay, but not the modified bromocresol purple assay, overestimates the serum albumin concentration in nephrotic syndrome through reaction with α2-macroglobulin
A study in patients with nephrotic syndrome found that the BCG assay had a mean bias of 6.2 g/L (roughly 0.6 g/dL) compared to a reference immunoassay, while the BCP assay was far more accurate with a bias of only 0.3 g/L. The researchers estimated that nephrologists relying on the BCG assay could reach inappropriate treatment decisions in up to 59% of patients, particularly regarding whether to start preventive blood thinners.17Kidney International. The bias between different albumin assays may affect clinical decision-making Similar concerns apply in chronic kidney disease more broadly.18PubMed. Albumin determined by bromocresol green leads to erroneous results in routine evaluation of patients with chronic kidney disease
If your albumin level seems inconsistent with your clinical picture, it is reasonable to ask which assay was used. This is not the kind of question most patients think to raise, but it can matter, especially in kidney disease where albumin levels guide treatment decisions about anticoagulation and other therapies.
When Albumin Quality Matters, Not Just Quantity
A measured albumin level tells you how much albumin is in the blood but says nothing about whether that albumin is functioning normally. In diseases associated with oxidative stress, including diabetes, chronic kidney disease, and liver failure, albumin molecules undergo chemical modifications such as oxidation, glycation, and carbamylation that change their shape and impair their ability to bind drugs and toxins.19PubMed. Clinical Implications Associated With the Posttranslational Modification-Induced Functional Impairment of Albumin in Oxidative Stress-Related Diseases Glycation, for example, alters albumin’s molecular weight and its secondary structure, reducing its transport and antioxidant functions.20PubMed Central. Advanced Glycation End Products of Bovine Serum Albumin Suppressed Th1/Th2 Cytokine but Enhanced Monocyte IL-6 Gene Expression via MAPK-ERK and MyD88 Transduced NF-κB p50 Signaling Pathways
This means two patients with identical albumin numbers on a lab test may have very different functional albumin status. A person with diabetes and an albumin of 3.6 g/dL may have substantially less effective albumin than a healthy person at the same level, because a larger share of their albumin molecules are glycated and structurally compromised. Current standard lab tests cannot distinguish functional from non-functional albumin, though research into this area is growing.
People Born Without Albumin
One of the most surprising facts about albumin is that a tiny number of people are born making essentially none of it. Congenital analbuminemia is an extremely rare inherited condition, with only a few dozen documented cases worldwide. You might expect that lacking the body’s most abundant plasma protein would be devastating, but most of these individuals live surprisingly normal lives with near-normal lifespans.21PubMed Central. Alterations in the Plasma Protein Expression Pattern in Congenital Analbuminemia – A Systematic Review
The body compensates by ramping up production of other plasma proteins, particularly lipoproteins, which can take over many of albumin’s transport duties. This compensatory increase is not enough to fully replace total protein levels, but it is enough to prevent the systemic edema and organ failure you would predict from the textbook role of albumin.22Biochimica et Biophysica Acta (BBA) – General Subjects. Congenital analbuminaemia: Molecular defects and biochemical and clinical aspects The main clinical features tend to be mild: slightly low blood pressure, modest ankle swelling, elevated cholesterol from the extra lipoproteins, and fatigue. The condition is a fascinating natural experiment showing that the body has more backup systems than anyone expected for a protein that seems, at first glance, irreplaceable.